INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (107727, 5175, NULL, NULL, NULL, NULL, NULL, NULL, NULL, X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, X'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', 'Hybrid', 1768159688, 1768159688, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (107728, 5176, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, X'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', 'NCBI', 1768159688, 1768159688, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (107729, 5176, NULL, NULL, NULL, NULL, NULL, NULL, NULL, X'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', NULL, NULL, NULL, NULL, X'789c558f316e03410845fb9c8203ac2c1739411a77be40e482996137280cac18c6966f93b3e464c64a1377f005bcc7798673b0290aece8d829c8078c2f9bd2a01074530e736ae0b44d41973be09a4350d01973bbc298be91df1760ad321beb061f70e5c0ce3a327553406d108e9580843a698c039c48c9132c586ee6dfffa8ab89d82da1a83a51e4e5b6f035f1ebd4fa1487a01149a9d677497b2862d6b29d1a4b4a8e14ccafb09864b5a3922c4f9bdf1fe19ddb5f7278fb7c3f5e1e831a6454', NULL, NULL, X'789c6d564d6fdb3810fd2b842fbd388a1da45d34b76681f6b0d8620fb96d16c1481c495c53a4ca0f3bdea2ff7ddfd0b22d3b390409447266de9bf766f273a143ee5e1c0dbc78508bad493418a7eac5522d5cbd79315a3e7f7ffce3d3fae3dde7cff239072bdffa94c6f8707bbbdbed2ad7d4a67276a89ce9abce6f6f6bef37f1f6f4ec56dec526d0c8fa85923cbf5bdd7dba59ad6fd6eba7f5c787fbf5c3fab772899b64bc8bb8f273d158e34c43f6259ace99167fbaa694f9d4fbdcf5aa63c781acddabec1a3f0cde2d554dc1500aa65131878ec35ee164b4785be22ac4503d6d599d6326754ca4ccecea12513587d8f8605ca752cfca316bd5fa506206eed945b3e5a51ab24d469bd8183c7724492970a57ebf486dcd8615398ac90f3ea142cbb4419ada222c522c95718983431d3d7e19c2d940d665c091084b3cd6aac3fbe0e5664c46ee9a18331f80058ea8046154e42d075416fdc0c90c2cd95bbe497d604aec0450839af84766701a2bf5d473e42bae7c8bab08fa239bc06a0c384c4a1bea9c8f06c52532d607509224eac06072b424cc49a1de755ef20c80dcb19c0a9c8d7c32a05c3009e542e78884388f2a79a46b18a41606558b9cc8082c28ae67b2a92fdf514bcb31a24ab248c7d4f4a8b6e5d2297e1d3924831720421bf92ca5e11dc5ead93d3b603db77cae2dc4903ebf21c2c4438b5b6a38b1aed45714cdaf843bbc7cdb5285d3eb5696fee0540b46d46792776000c5471e0b9b85b3d0e15a0b5e33509a56399f2602b5421b9a0dc42e1719a8e0942ddb7da5be1f1582749a810564e24762671083e4475f3faeefa0b270d412f037260f578f2e9564d1c71b601926fe857b28768822d7c666512e82f16068a97c4cec47e88b0e091ce7e0adef0ad3179c56eaafb86ffaf70fe7a135c369a5d52522b957c3692f52021341ba0cb6771e027182f42425d2ffe698846d1d6820694ed393eb6005a042974d50b5d7405ce28a3d62da5b21a0cd01e76156d3e47f68d36f65a68003b80620bea105259aaa834773e388b604500a258d1ef649e664d1e77cb75adf07d420f18ab4614eaa3d721cd89af511ee6ca09c6289f18229b929b3ed2d6d87046f27e0e460013ee674c84c6a6734c65108e011c54ae128d5c474f0c89fef8e347102704fb0c4ba7ec47831ff09a2897ae573425913afa47569dfc4205a602d972ea49ed2d4c111ba816c021d15fd4525a64262c15024815625b053e6cb9911d40bff3bed3150dcf98ba41efb7d2c244933699403dc44c053720b364bc764d6819209c18778d4ba401ec4a865cc49d0c98c3230c1c5d51e90a26f6a8a72778446642ccdf60cbc8b051320a1f8ce9e3a2af7c3cc72f0afe8ac649e4aaaf7d79c9e7016d0975a39a33b69f742ed93272ad9bd1350842d3b7f26c69160214cbe1055c4eab55ad5735e0277d95290d1848d11de629bfbf9f1388ce26112957a52c064556ccb9a105b1d36bbb254c3da9b59d6d65beb77a5192ecbee9fc7b6b229605f57fe8950b222659e8947503d16adf7187a3ecb2a429b50e0d9802366982dc279ceab15adac198d3e7c8521febe5ffdb3f8f5eb7fc674622c', 'Hybrid', 1768159688, 1768159688, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (107730, 5178, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, X'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', 'NCBI', 1768159688, 1768159688, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (107731, 5178, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, X'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', 'NCBI', 1768159688, 1768159688, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (107732, 5179, NULL, NULL, NULL, NULL, NULL, NULL, NULL, X'789ced585d4f1b3914fd2b569ea80a01fab195780b29d0aaa41b115a75b5a9a21bcfcdc48bc71ed91edad98affbec79300a10c9de2eedbee43a478e6dee3e3fbe57be75b2f73553e335470ef40f48e2baf32256703a9b2deb6e8554ec7c7cb104a7fb0bbfb455d70d1b72e8fffd4eef7d25e3a2a399b51884acff69efdb6b3b7bfb3bf77bef7eae0e5f383172ffb78f4eac5ab46966550d678487eeb9db06147baf91ff86ba37e5e977c3035afada79cc5b17585c772688bc21a71ee2863f11eacfd418356cd3701aff028d05c735cfdf9192badccc56a11df4d4a968af46c6ccb4ad32d8febbdc78e734346d6e20c6f4d3e35d8fa94646864f1ff8c0d69016ecdcb4156e9303563ce1405a7e4d4bce112a2f24189c7717e9858b78f5e47f7ae84fd4c99d90d42efaa31c5d09ae04819f8b1c51003add9e5b50856484ddeefc6684930f87849ae2069b5cdeb3b1bbc21bdd8d16a115d3d624058ad7c81c5d157e9786ded11cb25193c17762106cdae295e1f98a0e6cac22fb3091baf82bac48fef9eb805b7f78eef929e4c8dafbce412789a77fd1a8cc556e52bd2ba7e32356fa74699c0ae685c8e5797e414c8d56253d5b1573e9009d0389b9a9ba5d8b24e181b042f169109b0250e031fadd0274f41a146d2e490479c7d516129246b2dbe4042d0cd49fdd47c80e80dc305703f9cbf15d680c996412af9da072e80a1cc627568e07fda9f1a63454681b0783635b422a18c80cd9cdd16f32a34042bcfd90637483fff81f4ade0c6c922a71367ab520c840f8e4b51225c6a9383b2177879c3cc8bace2188c477db1200690c2013fbd48d971bd93e10a054551ef6ef05cdd0d26a460c3307affc45121c67665d0a8f6bbcb9be86c4223a2f6af8fb32d0eb7c5705b9c44b1db988bd1d47bdbc3161bb00f208daf097202c647e55446305b73d816804ffb3fc782e00c6311b9224f82398aa960a5951210d79e6b019a3c164755450a9fd1643248d87e7496a4361cec246a4e0295cbbe382a55865282cb36c568c3bef88b712bb4dbaa4bfbb42f107f56d6c1e6b8a6db08dc33779322ef39a79822fe7bc4f77d9103d1b9a5e5d6b0eea2048082515e63814833c9c83afa8a724902b71e81c903f1d819486ffab13ae98acddfad47e9ce8cbec0b5a85a54cf3a34df699e7b150fe1db72b24b7dbdf1ee2d8c389a1c9e3e4d81ba87f46e3c4c026ad27b8e62cece97db625094436138ffb7a04adbe6e42ea8093b87486e377377055d6b8b829c645cfd268903696461b2b3274b95272b8f9d0d8c7a5b284773959828d7209795ced109a5d8001097a88306adbbf0653fa9eedbb8684234116118db8b55588985e30a8d735bf23e0a27439574b85c7f1527f14803240a828bd026244538c63fc3e1c7243a7debb9cad62c883164c4768312800e2b77b1b41ad725a2047d3649950233098ceed1d972b92655900e5821fc53e0fe807fd18792e07503a3a12c53908e1d8637e59b100e185e5d544f8a9c4357c95fc98453ce95fd512e7575a763c2e451b906a1c07c6c259ad5a44b98b8687c53c5010173639d94921fd5dc291b2b94510b255bf3f17bf78c9497f75272a9a9a8b38611b5e754979747b5b425ca75713ba0b475175d30674a5e70085efd028d555aa3771474f993ddf6c050bc7bef777e717637b6a8656b1bd9d5b41d364c2cae00f4fe8ef2f4ab882f71193561c71a8f4dec6cdbd3b1b3b7d616b315ba50d827530b848dd2497de026d0561c5c6fd09e24d03aaefc86e30ccba692b9b46169cc65b0cd0419ae47aff68407abcff73fbbfcfff5e4bff1f5e4315fe3aeaefe0132405828', NULL, NULL, NULL, NULL, NULL, NULL, NULL, X'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', 'Hybrid', 1768159688, 1768159688, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (107733, 5180, NULL, NULL, NULL, NULL, NULL, NULL, NULL, X'789ced585d4f1b3914fd2b569ea80a01fab195780b29d0aaa41b115a75b5a9a21bcfcdc48bc71ed91edad98affbec79300a10c9de2eedbee43a478e6dee3e3fbe57be75b2f73553e335470ef40f48e2baf32256703a9b2deb6e8554ec7c7cb104a7fb0bbfb455d70d1b72e8fffd4eef7d25e3a2a399b51884acff69efdb6b3b7bfb3bf77bef7eae0e5f383172ffb78f4eac5ab46966550d678487eeb9db06147baf91ff86ba37e5e977c3035afada79cc5b17585c772688bc21a71ee2863f11eacfd418356cd3701aff028d05c735cfdf9192badccc56a11df4d4a968af46c6ccb4ad32d8febbdc78e734346d6e20c6f4d3e35d8fa94646864f1ff8c0d69016ecdcb4156e9303563ce1405a7e4d4bce112a2f24189c7717e9858b78f5e47f7ae84fd4c99d90d42efaa31c5d09ae04819f8b1c51003add9e5b50856484ddeefc6684930f87849ae2069b5cdeb3b1bbc21bdd8d16a115d3d624058ad7c81c5d157e9786ded11cb25193c17762106cdae295e1f98a0e6cac22fb3091baf82bac48fef9eb805b7f78eef929e4c8dafbce412789a77fd1a8cc556e52bd2ba7e32356fa74699c0ae685c8e5797e414c8d56253d5b1573e9009d0389b9a9ba5d8b24e181b042f169109b0250e031fadd0274f41a146d2e490479c7d516129246b2dbe4042d0cd49fdd47c80e80dc305703f9cbf15d680c996412af9da072e80a1cc627568e07fda9f1a63454681b0783635b422a18c80cd9cdd16f32a34042bcfd90637483fff81f4ade0c6c922a71367ab520c840f8e4b51225c6a9383b2177879c3cc8bace2188c477db1200690c2013fbd48d971bd93e10a054551ef6ef05cdd0d26a460c3307affc45121c67665d0a8f6bbcb9be86c4223a2f6af8fb32d0eb7c5705b9c44b1db988bd1d47bdbc3161bb00f208daf097202c647e55446305b73d816804ffb3fc782e00c6311b9224f82398aa960a5951210d79e6b019a3c164755450a9fd1643248d87e7496a4361cec246a4e0295cbbe382a55865282cb36c568c3bef88b712bb4dbaa4bfbb42f107f56d6c1e6b8a6db08dc33779322ef39a79822fe7bc4f77d9103d1b9a5e5d6b0eea2048082515e63814833c9c83afa8a724902b71e81c903f1d819486ffab13ae98acddfad47e9ce8cbec0b5a85a54cf3a34df699e7b150fe1db72b24b7dbdf1ee2d8c389a1c9e3e4d81ba87f46e3c4c026ad27b8e62cece97db625094436138ffb7a04adbe6e42ea8093b87486e377377055d6b8b829c645cfd268903696461b2b3274b95272b8f9d0d8c7a5b284773959828d7209795ced109a5d8001097a88306adbbf0653fa9eedbb8684234116118db8b55588985e30a8d735bf23e0a27439574b85c7f1527f14803240a828bd026244538c63fc3e1c7243a7debb9cad62c883164c4768312800e2b77b1b41ad725a2047d3649950233098ceed1d972b92655900e5821fc53e0fe807fd18792e07503a3a12c53908e1d8637e59b100e185e5d544f8a9c4357c95fc98453ce95fd512e7575a763c2e451b906a1c07c6c259ad5a44b98b8687c53c5010173639d94921fd5dc291b2b94510b255bf3f17bf78c9497f75272a9a9a8b38611b5e754979747b5b425ca75713ba0b475175d30674a5e70085efd028d555aa3771474f993ddf6c050bc7bef777e717637b6a8656b1bd9d5b41d364c2cae00f4fe8ef2f4ab882f71193561c71a8f4dec6cdbd3b1b3b7d616b315ba50d827530b848dd2497de026d0561c5c6fd09e24d03aaefc86e30ccba692b9b46169cc65b0cd0419ae47aff68407abcff73fbbfcfff5e4bff1f5e4315fe3aeaefe0132405828', NULL, NULL, NULL, NULL, NULL, NULL, NULL, X'789c9554c16edc3610fd95c102065260a3dd559c06f62deda541e11e6a033dd481419123893597a392d4aa8b20ffde3794e320095a20875d489ae19bf7deccf0c3c6a5797888e6c89b6bdaf473f6ce5b32d6bbcd9636b17b7cc01322bffdf4ebebabf6b27da39fe714f4db58ca94af77bb65599a683bdfc4706ca21f9b414ebb4ee431ef9e8fedf45cb6c94cec1e4cd1e3edbefdf1e5fef0f270b83bbcbe6eafae2faf6a12dbe22566a47cd8d8e0a3b7263c643f44dfe331dacaf4f6f61d25533893e90b27bab9b92504e964d2991c4f1c9d8f0349a4ded82229539eed48265319994c34458e109a7de12dd920794e4c472ea3b82dc28e047949e1bce902e7867e91854f9cb60a90f953719c1a387232219c29c882f07952c6784d260e4aa24f7244a6cc803d3497175484dae6cd45731fff3cbcbf8ff7f1f70a263d81b658939c2f3e571a53928c82055cff121f0bf9d8af06d5da6014b52ca786de42623af19916a8cc8c5cd451b56f8f9cd439fa5942e081b5d08d8c996ee73430fc3af2b16358e423b5fb43dbd01fbe8cd4beda53e23c497400cb55384a2efa1705a14952a9ac9f389df84bfe3dcac9a20e18b273319165d63eac45abc9113649e42730c5fa6fc10ddd41ccff18b282b0534c6be794d87dc1213f42e0e7741433d47999f2b9ce01f499027a5de6bf6728064c66760051131f23f35a51dbd6b6e8db3bf4c0a95489d59c3a130adb61e4e0d2d19ba7e9fc56bdb6779d883d268196d1633af1b1f65299c48a38fa41c790d52b7823e0a9367741c40135148c6da6176d73b8f8015a150f1a4736a18c679a4cf1dabacaf8559db4bb11457299dd99ac441be6551f847fc5111b4882799fb3ae4bf1300a9e6b5393f6601acfc1fce3bf7b683b9359fb5ed5d51e213cccde31369df3b3b795a7aa0ff895756bd765f4c197b3aa9c126cf6166e7059187bf0cc5b39e801b4cce912f462214bab732ecfe7b286cc49bc431ba11442b9579e1875ed2b660609738c8cdcacf7caeaabd5c5cb9f6e18532db7894d5e5f8bc7c592a4f326e8faf85cf4cedaead523735195a8d7c1da66f3f1e3bf7cb6f878', 'Hybrid', 1768159688, 1768159688, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (107734, 5181, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, X'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', X'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', X'789c458fb14e04310c44fbfb8a29413a6d498fa8a841f4267136d6651d94380b775fc3b7f065384b41e166fc663c7e8c3bb7cee094385887682823323253a490b99f91cae859743d43697426d486bd6e6287461a11e57613e5de71f7fc0667ee17bc666e0cf269fc519b47d7844dd6464efec7e3532c831049ca15b17a15e71eb02ea7d38bac2a4902a981b63af42f6417a34d144ff0cd2cdc98dc66d94f49bf4ce42251f98a6ed55b1d15b9f04ec6184d0228483cd4fa4565aaef1ce66b3fdf62c7d2afba6f263aafbcfc02cbcb6a33', NULL, X'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', X'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', X'789c1d8d4b0ec2400c43afe2256cb80477606fcd8469a4f9a0242deaed49d958b6643fbf343874e2895b6a330ebfa330ad1e8237bb0ba634c6153dd6ea683b950526bef7707056a8c368d24fd07d156548c557634b42b027d0eab5a1d976c636948ebcfb24566632fe55b535b10eb1be581f3fa5f73858', X'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', 'NCBI', 1768159688, 1768159688, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (107735, 5181, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, X'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', X'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', X'789c75903172c34008457b9f8203d82ad3a7cc095c64526084b44c568b06d824ba8dcfe2930569e232ddcef279ff7fdedacc1ea20d16dca0328e100a511826b5058f894ee06142d18d3d67a67d2edae390cd983395163ba6618530a418e0957a3054f9628309a5e62e10268ca81b8c9d779f518c2980745d5316fa2324b15da48d9d3893887b0a1b93a98b0fa7f7978fd3b570fa1aac198e5b38609231401a19a3e79a897feea10ba746896bed152ddd8da4e982200e4dd336ebda196e7b93cc82c1e7fccfae7ddca0a0c3c6015ef4bb41067ff2f3f1b8ff877edc31f25489c45b3d2afe7593e79d875f62778b7f', NULL, X'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', X'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', NULL, X'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', 'NCBI', 1768159688, 1768159688, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (107736, 5181, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, X'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', 'NCBI', 1768159688, 1768159688, NULL, NULL, NULL, NULL, NULL, NULL, NULL);